The Paired Perils of Breast Cancer and Diabetes
May 30, 2022
UC San Diego researchers discover mechanism linking breast cancer and diabetes, each of which promotes development and growth of the other.
News Archive
News Archive - School of Medicine
1 million Youth Became Daily Tobacco Users, Most Used JUUL E-cigarettes
May 30, 2022
More than 1 million United States youth became new daily tobacco users within two years, most were vaping e-cigarettes daily, report UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science researchers.
New Weight-Loss Intervention Targets Instinctive Desire to Eat
May 18, 2022
People who are highly responsive to food lost more weight and kept it off using a new weight loss program that targets internal hunger cues and the ability to resist food, reports University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science.
COVID-19, MIS-C and Kawasaki Disease Share Same Immune Response
May 16, 2022
COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.
Pharmacists at Higher Risk of Suicide than General Population, Study Finds
May 13, 2022
UC San Diego study shows suicide rates were higher in pharmacists than in the general population between 2003 and 2018, with job problems being the most significant feature associated with the suicides.
Gene Therapy Shows Promise in Treating Neuropathy from Spinal Cord Injuries
May 9, 2022
An international team of researchers, led by scientists at UC San Diego, report that a gene therapy that inhibits targeted nerve cell signaling effectively reduced neuropathic pain with no detectable side effects in mice with spinal cord or peripheral nerve injuries.
Targeting Molecular Pathway that Causes Pulmonary Arterial Hypertension
May 6, 2022
UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.
Arrhythmia Mapping Technology Demonstrates Positive Clinical Results
May 4, 2022
Bioengineers and cardiologists from UC San Diego invented a technology that can accurately and noninvasively map atrial and ventricular heart arrhythmias in a matter of minutes. The technology demonstrated 97.3 percent accuracy in a clinical validation study, and recently received FDA clearance.
Study of Promising Alzheimer’s Marker in Blood Prompts Warning About Brain-Boosting Supplements
May 3, 2022
Elevated levels of an enzyme called PHGDH in the blood of older adults could be an early warning sign of Alzheimer’s disease. Research led by UC San Diego has consistently found high levels of PHGDH expression in brain tissue and blood samples of older adults with different stages of the disease.
Gene Therapy Reverses Effects of Autism-Linked Mutation in Brain Organoids
May 2, 2022
UC San Diego scientists use lab-grown human brain tissue to identify neural abnormalities in Pitt-Hopkins Syndrome and show gene therapy tools can rescue neural structure and function.
